thiazolyl blue has been researched along with tanespimycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asad, Y; Banerji, U; Eccles, SA; Jackman, AL; Judson, I; Raynaud, F; Ruddle, R; Sain, N; Sharp, SY; Valenti, M; Walton, M; Workman, P | 1 |
| Alcazar, A; Cid, C | 1 |
| Gu, X; Yang, W; Zhang, J; Zhang, T; Zhao, Y; Zheng, Z | 1 |
3 other study(ies) available for thiazolyl blue and tanespimycin
| Article | Year |
|---|---|
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Blotting, Western; Carboplatin; Cell Line, Tumor; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Ovarian Neoplasms; Rhodamines; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2008 |
High cytotoxic sensitivity of the oligodendrocyte precursor cells to HSP90 inhibitors in cell cultures.
Topics: Animals; Benzoquinones; Cell Differentiation; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Gangliosides; Glial Fibrillary Acidic Protein; HSP90 Heat-Shock Proteins; Inhibitory Concentration 50; Lactams, Macrocyclic; Macrolides; O Antigens; Oligodendroglia; Rats; Stem Cells; Tetrazolium Salts; Thiazoles; Tubulin | 2009 |
The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Flow Cytometry; Formazans; Gene Expression Profiling; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Staining and Labeling; Tetrazolium Salts; Thiazoles | 2013 |